Abstract:Aim To design and synthesize 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-(4-alkyloxyphenylpiperazin-1-yl)-2-propanols and 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-substituted sulfur ether-2-propanols and investigate their antifungal activities in vitro.Methods The desired compounds were synthesized through the reaction of the intermediate epoxide and 4-alkyloxyphenylpiperazines or substituted sulfur alcohols and confirmed by the elementary analysis,~1H-NMR and IR spectra.MIC_(80) of all the title compounds were determined by the method recommended by the National Committee for Clinical Laboratory Standards(NCCLS)using the RPMI1640 test medium.Results Twelve compounds were synthesized.The results of the preliminary antifungal test showed that all the title compounds exhibited potent antifungal activities to a certain extent.The antifungal activity of 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-(4-alkyloxyphenylpiperazin-1-yl)-2-propanols was more potent than that of 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-substituted sulfur ether-2-propanols in vitro.Conclusion The antifungal activities of the four compounds in 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-(4-alkyloxyphenylpiperazin-1-yl)-2-propanols are more potent than that of fluconazole or equal to that of ketoconazole in vitro.

Synthesis of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluoro-phenyl)-3-[n-cyclopropyl-n-substituted Amino]-2-propanols and Test of Its Antifungal Activity

Synthesis of 1-(1H-1, 2, 4-triazole-1-yl)-2-(2, 4-difluoro-phenyl)-3-(N-cyclopropyl-N-substituted amino)-2-propanols and its antifungal activity

Synthesis and Antifungal Activities of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)- 3-[(4-Substituted-piperazine)-1-yl]-2-propanols

Synthesis and Antifungal Activity of 1-(1H-1,2,4-triazol-1-yl)-2-(3,3-dimethyl)-3-[(4-substituted)-piperazin-1-yl]-2-propanols

Synthesis and Antifungal Activities of 1-(1H-1, 2, 4-Triazol- 1- Yl )-2-( T-Butyl )-3-( O-substituted ) -2- Propanols

Synthesis and Antifungal Activity of Triazole Derivatives with Side Chain Containing Tert-Butyl and 4-Substitued-piperazin-1-yl

Synthesis and Antifungal Activities of 1-(1 H-1,2,4- Triazol-1-yl)-2-(3,3-dimethyl)-3-[(4-substituted)-piperazin-1-yl]-2-propanols

Synthesis and the Antifungal Activities of 1-(1H-1,2,4-triazole-1-yl)-2-(t-butyl)-3-[(4-substituted Benzyl)-Piperazin-1-yl]-2-propanols

Synthesis and antifungal activity of the novel triazole compounds

Design, Synthesis and Antifungal Evaluation of 1-(2-(2,4-Difluorophenyl)-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)-1h-1,2,4-triazol-5(4h)-one

Synthesis and the Antifungal Activities of 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-substituted Group-2-propanols

Synthesis of New Antifungal Agents--triazole Propanol Derivatives Containing Nitrogen

Molecular Docking, Design, Synthesis and Antifungal Activity Study of Novel Triazole Derivatives Containing the 1,2,3-Triazole Group

Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.

Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent

Synthesis, in Vitro Evaluation and Molecular Docking Studies of New Triazole Derivatives As Antifungal Agents.

Synthesis, In Vitro Biological Evaluation, and Molecular Docking of New Triazoles as Potent Antifungal Agents.

Synthesis and Antifungal Activity of 3-Methyl-4-amino-5-mercapto-1,2,4-triazole Derivatives

Design, synthesis and in vitro biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Design, synthesis, and antifungal activities of novel 1H-triazole derivatives based on the structure of the active site of fungal lanosterol 14 alpha-demethylase (CYP51).

Design, Synthesis, and in Vitro Evaluation of Novel Triazole Analogues Featuring Isoxazole Moieties As Antifungal Agents.